Our Sectors
We are experts at what we do
01
Our People
A dedicated team of executive search experts, delivering for you
The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.
Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.
02
Expertise
Unearthing rare talent, that drive successful exits
Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.
03
Our Approach
Tailoring our offering,
to provide a bespoke service
Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.
A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors
What our clients say
“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”
Outcomes First Group – Chair
“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.”
Hengrui Therapeutics – VP, Head Biological Drug Discovery
“Compass Carter Osborne delivered on a key appointment for the PFA and the wider football industry. It was a complex brief involving creating an entirely new position. The role was vitally important, with the successful candidate taking on a sensitive and multifaceted responsibility across CTE, concussion and brain health in professional football. CCO led a comprehensive and exhaustive process, developing a deep understanding of the union’s requirements and using his expert knowledge to help scope and evolve the brief throughout the search. The entire process was professional, efficient and well organised, with consistent communication and feedback at every stage.”
The Professional Footballers Association (PFA) – Chief Executive Officer
“I have been so impressed by Luke’s integrity, clear purpose and drive to achieve for his clients. Luke has worked with Priory on a number of things but more recently to source two independent Non Executive Directors and a Director of Talent Acquisition. He has kept us informed, fielded some great candidates and follows up at each stage, even when they have started. I would really recommend him if you are searching for high calibre individuals.”
Priory Group – Chief Executive Officer
“I recently had the pleasure of being appointed to an independent healthcare provider as a NED after being put forward for the role by Luke. Throughout the whole recruitment process I was treated with respect and felt valued. I was particularly impressed with the follow up support after the decision to appoint me, which I have never experienced from other search companies. Luke continued to check in with me to ensure my onboarding went smoothly and that I had settled into the role. Overall, a highly professional and comprehensive approach delivered personally by Luke.”
Priory – Independent Non-Executive Director
“Luke was absolutely brilliant along the journey. He acted as a real partner and was able to answer to all my questions in order to get comfortable with the decision of making the change. His expertise and knowledge of the sector really came out along the process. Most importantly, he was always available when I needed him to be, which is something I valued a lot. In summary, I couldn’t recommend him and Compass Carter Osborne enough.”
AniCura – Group Chief Operating Officer
“We worked with Compass Carter Osborne in the search for our Chief Financial Officer and from the start it was clear they were a good choice of partner. A focus on understanding our needs as a business, and mine personally as a CEO were front of mind for Paul and Kieran. They took the time to listen, understand and not only focus on the functional aspects of the role – but critically, the team fit and culture we are building.
Process, structure and follow-through were like clockwork, and the quality of candidates were of a consistently high-level. I would highly recommend Compass Carter Osborne.”
Renaiss Health – Chief Executive Officer
“I’ve known Tarquin for over 15 years, during which time he has delivered a number of executive assignments at senior level, including COO/executive team and senior management roles in scientific/professional disciplines (his network in the biotech/life-sciences sector is second-to-none!). He works hard to truly understand both the candidate brief and the culture of the company, sets realistic expectations and retains regular contact as an assignment progresses, always providing thorough updates and pragmatic advice. He has the highest levels of professionalism and integrity – he really is a pleasure to work with.”
One Nucleus – Director
“Jamie did a great job – he really took the time to understand our business, our needs and what we were looking for. We knew our brief was specific, yet Jamie met all our expectations with the search. He maintained a high standard of communication and meticulous attention to detail throughout the process. I would recommend Jamie and the Compass Carter Osborne team without hesitation.”
Melrose Education – Chair & CEO
“Our recent work with Compass Carter Osborne was exceptional. The search was perfectly organised, response times were swift, and due to the consultant market knowledge and network, we quickly found our ideal candidate.”
Schoen Clinic – Member of Group Executive
Healthcare news, data and analysis
Via Investors in Healthcare
France: Charles River Laboratories to acquire PathoQuest from SHS Capital
Germany-based healthcare investor SHS Capital is selling PathoQuest, a specialist in NGS-based quality control assays for biopharmaceuticals, to the strategic Charles River Laboratories, a global provider of products and services […]
Germany-based healthcare investor SHS Capital is selling PathoQuest, a specialist in NGS-based quality control assays for biopharmaceuticals, to the strategic Charles River Laboratories, a global provider of products and services […]
France: Charles River Laboratories to acquire PathoQuest from SHS Capital
January 13, 2026
M&A
News
Pharma
Services – CRO/CMO/CDMO
Charles River Laboratories
UK: Octopus Capital appoints head of Real Assets and co-heads of Real Estate Investment
Ed Clough has been promoted to the newly created role of head of Real Assets for Octopus Capital. Clough will continue to have responsibility for the real estate business but now takes on leadership […]
Ed Clough has been promoted to the newly created role of head of Real Assets for Octopus Capital. Clough will continue to have responsibility for the real estate business but now takes on leadership […]
UK: Octopus Capital appoints head of Real Assets and co-heads of Real Estate Investment
January 13, 2026
Care Homes
News
People
Real Assets
Social Care
Malaysia: Sunway Healthcare preparing IPO in Malaysia to fund expansion plans
Press reports point to Sunway Healthcare Group (SHG) about to gauge investor interest for its proposed IPO in Malaysia. The IPO could raise around US$700m, says Bloomberg. In September 2025, […]
Press reports point to Sunway Healthcare Group (SHG) about to gauge investor interest for its proposed IPO in Malaysia. The IPO could raise around US$700m, says Bloomberg. In September 2025, […]
Malaysia: Sunway Healthcare preparing IPO in Malaysia to fund expansion plans
January 13, 2026
Healthcare
Hospitals and Clinics
News
Public Equity
Real Assets
Netherlands: Colesco Capital supports TopzorgGroep’s acquisition of FysioHolland
Colesco Capital (Colesco), a sustainability-led private credit specialist, is supporting TopzorgGroep’s acquisition of FysioHolland, a major provider of physiotherapy and rehabilitative care in the Netherlands. Backed by Capital A, TopzorgGroep is a […]
Colesco Capital (Colesco), a sustainability-led private credit specialist, is supporting TopzorgGroep’s acquisition of FysioHolland, a major provider of physiotherapy and rehabilitative care in the Netherlands. Backed by Capital A, TopzorgGroep is a […]
Netherlands: Colesco Capital supports TopzorgGroep’s acquisition of FysioHolland
January 13, 2026
Buy Out
Consumer Healthcare
Debt
Healthcare
M&A
Luxembourg: Apheon closes AMB VI at the hard cap of €1.25bn
Apheon Management has reached the €1.25bn hard cap for its sixth flagship fund vintage, Apheon MidCap Buyout VI. In addition, €50m will be invested by the Apheon team and related […]
Apheon Management has reached the €1.25bn hard cap for its sixth flagship fund vintage, Apheon MidCap Buyout VI. In addition, €50m will be invested by the Apheon team and related […]
Luxembourg: Apheon closes AMB VI at the hard cap of €1.25bn
January 12, 2026
Healthcare
News
Apheon
Arendt & Medernach
Evercore
Spain: Eugin becomes second-largest fertility group in Spain with acquisition of Instituto Bernabeu
Eugin Group, an international group of assisted reproduction and fertility centres and part of Buenavista Equity Partners (formerly GED Capital), has invested in Spain-based fertility clinic Instituto Bernabeu. With this […]
Eugin Group, an international group of assisted reproduction and fertility centres and part of Buenavista Equity Partners (formerly GED Capital), has invested in Spain-based fertility clinic Instituto Bernabeu. With this […]
Spain: Eugin becomes second-largest fertility group in Spain with acquisition of Instituto Bernabeu
January 12, 2026
Buy Out
Healthcare
Hospitals and Clinics
M&A
News
UK: Inflexion appoints John DiGiovanni as head of Healthcare
European mid-market private equity firm Inflexion has appointed John DiGiovanni as head of Healthcare, further strengthening the firm’s healthcare expertise. He will work closely with Andy Neville, partner in the […]
European mid-market private equity firm Inflexion has appointed John DiGiovanni as head of Healthcare, further strengthening the firm’s healthcare expertise. He will work closely with Andy Neville, partner in the […]
UK: Inflexion appoints John DiGiovanni as head of Healthcare
January 12, 2026
Healthcare
Life Sciences
News
People
Pharma
Ireland: Haemonetics Corporation acquires Vivasure Medical for up to €185m
Vivasure Medical, an Ireland-based medtech firm, has been acquired by Haemonetics Corporation, a US-listed global medtech company, in a transaction valued at up to €185m (US$216m) subject to completion of […]
Vivasure Medical, an Ireland-based medtech firm, has been acquired by Haemonetics Corporation, a US-listed global medtech company, in a transaction valued at up to €185m (US$216m) subject to completion of […]
Ireland: Haemonetics Corporation acquires Vivasure Medical for up to €185m
January 12, 2026
Life Sciences
M&A
Medtech – Hospital Equipment
News
Andrew Glass
UK: Bridgepoint-backed Prescient Healthcare Group acquires Uptake
UK-based Prescient Healthcare Group, an international consulting partner to the biopharmaceutical industry, has acquired Uptake Strategies, a UK-based global healthcare consultancy, bringing together two organisations focused on the pharmaceutical and […]
UK-based Prescient Healthcare Group, an international consulting partner to the biopharmaceutical industry, has acquired Uptake Strategies, a UK-based global healthcare consultancy, bringing together two organisations focused on the pharmaceutical and […]
UK: Bridgepoint-backed Prescient Healthcare Group acquires Uptake
January 12, 2026
Buy Out
Healthcare
M&A
News
Pharma
Europe: Aedifica invests nearly €110m in six care properties across Europe
Belgium-listed Aedifica, a specialist healthcare real estate investor focusing on housing for elderly people with care needs, has expanded its European healthcare portfolio by investing €108.5m (US$126.4m) in six care […]
Belgium-listed Aedifica, a specialist healthcare real estate investor focusing on housing for elderly people with care needs, has expanded its European healthcare portfolio by investing €108.5m (US$126.4m) in six care […]
Europe: Aedifica invests nearly €110m in six care properties across Europe
January 9, 2026
Care Homes
M&A Deals
News
Real Assets
Retirement Housing
Unlocking deal value: how operational due diligence shapes healthcare value creation
The traditional approach to healthcare deal-making is undergoing a fundamental shift. As financial leverage becomes less effective and market volatility increases, operational due diligence (ODD) has emerged as a critical […]
The traditional approach to healthcare deal-making is undergoing a fundamental shift. As financial leverage becomes less effective and market volatility increases, operational due diligence (ODD) has emerged as a critical […]
Unlocking deal value: how operational due diligence shapes healthcare value creation
January 9, 2026
Analysis
M&A
News
Pharma
Services – CRO/CMO/CDMO
Netherlands: Antin to acquire Emsere from Gryphion
Antin Infrastructure Partners, a France-based private equity firm focused on infrastructure, is to acquire Emsere, a one-stop shop for medical equipment rental and support services for clinical trials, from Gryphion, […]
Antin Infrastructure Partners, a France-based private equity firm focused on infrastructure, is to acquire Emsere, a one-stop shop for medical equipment rental and support services for clinical trials, from Gryphion, […]
Netherlands: Antin to acquire Emsere from Gryphion
January 9, 2026
Buy Out
M&A
M&A Deals
News
Pharma
Queen’s Park Equity (QPE), a UK-based provider of capital and expertise to entrepreneur-led businesses within the Education, Health & Pharma and Tech Services sectors, has announced that Matt Coffey has joined the firm’s […]
Netherlands: European Dental Group expands European footprint with acquisition of Fresh
Nordic Capital-backed European Dental Group (EDG), a dental service organisation operating in five European countries, has acquired Fresh, including Fresh Tandartsen, Fresh Unieke Mondzorg and Fresh’s dental laboratories in the […]
Nordic Capital-backed European Dental Group (EDG), a dental service organisation operating in five European countries, has acquired Fresh, including Fresh Tandartsen, Fresh Unieke Mondzorg and Fresh’s dental laboratories in the […]
Netherlands: European Dental Group expands European footprint with acquisition of Fresh
January 8, 2026
Buy Out
M&A
News
European Dental Group (EDG)
Greenberg Traurig
Germany: Asker Healthcare to acquire German Healthcare and Medicalprodukte Vertrieb Flensburg
Asker Healthcare Group has started 2026 with another proposed acquisition, signing an agreement to acquire German Healthcare and Medicalprodukte Vertrieb Flensburg (GHC/MPF), two interlinked medical supplies companies within the homecare […]
Asker Healthcare Group has started 2026 with another proposed acquisition, signing an agreement to acquire German Healthcare and Medicalprodukte Vertrieb Flensburg (GHC/MPF), two interlinked medical supplies companies within the homecare […]
Germany: Asker Healthcare to acquire German Healthcare and Medicalprodukte Vertrieb Flensburg
January 8, 2026
Homecare
Life Sciences
M&A
Medtech – Medical Devices and Implants
News
Germany: Liana Frank takes up managing director position at TSC Real Estate
Berlin-based TSC Real Estate, a specialist integrated and sustainable investment and asset management of senior citizens’ and healthcare properties as well as real estate in the health and life sciences […]
Berlin-based TSC Real Estate, a specialist integrated and sustainable investment and asset management of senior citizens’ and healthcare properties as well as real estate in the health and life sciences […]
Germany: Liana Frank takes up managing director position at TSC Real Estate
January 7, 2026
Care Homes
Healthcare
Hospitals and Clinics
News
People
Croatia: MidEuropa acquires majority stake in optical retail chain Optika Anda
Leading private equity investor in Central Europe, MidEuropa, has acquired a majority stake in Croatia-based optical retail chain Optika Anda. MidEuropa will invest alongside the second-generation owner and board member […]
Leading private equity investor in Central Europe, MidEuropa, has acquired a majority stake in Croatia-based optical retail chain Optika Anda. MidEuropa will invest alongside the second-generation owner and board member […]
Croatia: MidEuropa acquires majority stake in optical retail chain Optika Anda
January 7, 2026
Buy Out
Healthcare
M&A
News
Ophthalmology
Israel: Matrix One expands Life Sciences Software offering with acquisition of Simploud
Germany-based Matrix One, a provider of software solutions for life sciences organisations, has acquired Israel-based Simploud, a cloud-based provider of Quality Management System (QMS) and Laboratory Information Management System (LIMS) […]
Germany-based Matrix One, a provider of software solutions for life sciences organisations, has acquired Israel-based Simploud, a cloud-based provider of Quality Management System (QMS) and Laboratory Information Management System (LIMS) […]
Israel: Matrix One expands Life Sciences Software offering with acquisition of Simploud
January 7, 2026
Buy Out
Life Sciences
M&A
News
Israel
US: STAAR to terminate merger agreement with Alcon
Nasdaq-listed STAAR Surgical, a designer, developer and manufacturer of implantable lenses for the eye, has announced that based on preliminary estimates by STAAR’s proxy solicitor, STAAR did not receive the […]
Nasdaq-listed STAAR Surgical, a designer, developer and manufacturer of implantable lenses for the eye, has announced that based on preliminary estimates by STAAR’s proxy solicitor, STAAR did not receive the […]
US: STAAR to terminate merger agreement with Alcon
January 7, 2026
Healthcare
News
Ophthalmology
Public Equity
Alcon
UK: Dark Blue Therapeutics acquired by Amgen for up to US$840m
Oxford-based Dark Blue Therapeutics, a discovery and development biotech spinout Nasdaq-listed multinational biopharma Amgen. The acquisition adds to Amgen’s portfolio an investigational small molecule that targets and degrades two proteins […]
Oxford-based Dark Blue Therapeutics, a discovery and development biotech spinout Nasdaq-listed multinational biopharma Amgen. The acquisition adds to Amgen’s portfolio an investigational small molecule that targets and degrades two proteins […]
UK: Dark Blue Therapeutics acquired by Amgen for up to US$840m
January 7, 2026
M&A
Manufacturing – Specialty Pharma
News
Pharma
Alastair MacKinnon
UK: Colliers’ Healthcare team advises on sale of Athena Healthcare Group – more to come
The Colliers Healthcare team has advised on the off-market disposal of Athena Healthcare Group, in a deal which includes the sale of 12 elderly care assets, alongside the operational platform. […]
The Colliers Healthcare team has advised on the off-market disposal of Athena Healthcare Group, in a deal which includes the sale of 12 elderly care assets, alongside the operational platform. […]
UK: Colliers’ Healthcare team advises on sale of Athena Healthcare Group – more to come
January 6, 2026
Care Homes
M&A
M&A Deals
News
Real Assets
UK: LDC backs myHappymind with minority investment
myHappymind, a provider of digital mental health and wellbeing programmes for schools, has secured a minority investment from LDC, part of Lloyds Banking Group. The partnership will enable myHappymind to […]
myHappymind, a provider of digital mental health and wellbeing programmes for schools, has secured a minority investment from LDC, part of Lloyds Banking Group. The partnership will enable myHappymind to […]
UK: LDC backs myHappymind with minority investment
January 6, 2026
Education
News
Venture
Al-Munther Sultan
Alex Kirkby
Hong Kong: Insilico Medicine raises US$292m from Hong Kong IPO
Insilico Medicine, a clinical-stage drug discovery and development company, listed on the Hong Kong Stock Exchange at the end of December, becoming the first AI-driven biotech company to go public […]
Insilico Medicine, a clinical-stage drug discovery and development company, listed on the Hong Kong Stock Exchange at the end of December, becoming the first AI-driven biotech company to go public […]
Hong Kong: Insilico Medicine raises US$292m from Hong Kong IPO
January 6, 2026
Manufacturing – Specialty Pharma
News
Pharma
Public Equity
CICC
Switzerland: Healthcare Holding Schweiz expands with acquisition of majority stake in Medddbase International
Healthcare Holding Schweiz, a provider of medical technology products and services, has started the new year with the announcement of an acquisition of a majority interest in Switzerland-based Medddbase International, a […]
Healthcare Holding Schweiz, a provider of medical technology products and services, has started the new year with the announcement of an acquisition of a majority interest in Switzerland-based Medddbase International, a […]
Switzerland: Healthcare Holding Schweiz expands with acquisition of majority stake in Medddbase International
January 6, 2026
Buy Out
Distribution
Healthcare
Life Sciences
M&A
UK: Andrew Nicholson rejoins Rothschild & Co | Arrowpoint Advisory as managing director in the healthcare team
Andrew Nicholson has started in his new position as managing director in the healthcare team at Rothschild & Co | Arrowpoint Advisory. Nicholson has specialised in M&A for 25 years. […]
Andrew Nicholson has started in his new position as managing director in the healthcare team at Rothschild & Co | Arrowpoint Advisory. Nicholson has specialised in M&A for 25 years. […]
UK: Andrew Nicholson rejoins Rothschild & Co | Arrowpoint Advisory as managing director in the healthcare team
January 6, 2026
Healthcare
Life Sciences
News
People
Pharma
The latest insights from
Compass Carter Osborne
Digital transformation or change fatigue? Navigating tech in health and care
Digital transformation or change fatigue? Navigating tech in health and care
November 24, 2025
Healthcare
Insight
Culture in flux: rebuilding trust in a multi-generational workforce
Culture in flux: rebuilding trust in a multi-generational workforce
October 24, 2025
Healthcare
Insight
